4th Circ. Sides With CMS' Definition Of 'Line-Extension Drug'
By Yeji Jesse Lee · April 10, 2024, 7:12 PM EDT
The Fourth Circuit on Wednesday affirmed a summary judgment ruling in favor of the Centers for Medicare & Medicaid Services in a rule challenge by Vanda Pharmaceuticals, which took issue with...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login